Agilent Q3 Revenues up 2 Percent; Lowers FY 2012 Estimates | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies reported after the close of the market on Wednesday that revenues during its fiscal third quarter inched up 2 percent year over year as the company missed the average analyst estimate on the top and bottom line.

For the three months ended July 31, revenues totaled $1.72 billion, compared to $1.69 billion for the third quarter a year ago. The company fell short of the average analyst estimate of $1.79 billion.

Orders during the quarter were down 2 percent to $1.66 billion from $1.69 billion a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.